Crossmark Global Holdings, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1539204
HOUSTON, TX
Position in NBIX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,466,466
+$351,024 QoQ
Shares Held
8,701
+2.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#350
of 772 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $32,206,115 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
783,835 | $12,564,875 | |
| 2 | HLN |
Haleon plc
|
749,194 | $6,989,980 | |
| 3 | ZTS |
Zoetis Inc.
|
63,238 | $4,544,282 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,957 | $1,602,191 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,701 | $1,466,466 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
39,372 | $968,944 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
84,915 | $913,685 | |
| 8 | ALKS |
Alkermes plc.
|
12,517 | $655,828 |
All Filings in NBIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,466,466 | 8,701 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,115,442 | 8,467 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,186,691 | 8,367 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,103,106 | 7,858 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,008,285 | 8,022 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $971,621 | 8,785 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,155,472 | 8,465 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $977,871 | 8,487 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,002,649 | 7,283 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,095,084 | 7,940 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,061,458 | 8,056 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $961,537 | 8,547 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $852,094 | 9,036 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $952,985 | 9,415 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,099,205 | 9,203 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $986,265 | 9,286 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $915,434 | 9,391 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $889,781 | 9,491 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $809,200 | 9,501 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $1,005,232 | 10,481 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,028,769 | 10,571 | Shares | Sole | 2021-07-21 | |
| No filing history on record for this holder in this stock. | ||||||